Search results
The pages "Biodrugs" and '"Biodrugs"' do not exist. You can create a draft and submit it for review or request that a redirect be created, but consider checking the search results below to see whether the topic is already covered.
- BioDrugs is a peer-reviewed pharmacology journal. BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and...1 KB (48 words) - 01:08, 3 July 2024
rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis". BioDrugs. 23 (2): 125–35. doi:10.2165/00063030-200923020-00005. PMID 19489653. S2CID 195685167...14 KB (1,061 words) - 20:28, 8 May 2024- (2004). "Costimulation blockade in the treatment of rheumatic diseases". BioDrugs. 18 (2): 95–102. doi:10.2165/00063030-200418020-00003. PMID 15046525. S2CID 24762590...2 KB (117 words) - 00:06, 1 June 2023
marketed in the US or in Europe. "Abetimus: Abetimus sodium, LJP 394". BioDrugs. 17 (3). Springer Nature Switzerland AG: 212–5. 2003. doi:10...3 KB (174 words) - 21:49, 22 January 2023- Related Agents for Chronic Musculoskeletal Pain: A Comprehensive Review". BioDrugs. 35 (6): 611–641. doi:10.1007/s40259-021-00504-8. PMID 34807432. S2CID 244509341...2 KB (142 words) - 14:19, 26 September 2023
- IL-17F for the Treatment of Psoriatic Disease and Ankylosing Spondylitis". BioDrugs. 33 (4): 391–399. doi:10.1007/s40259-019-00361-6. PMID 31172372. S2CID 174812750...11 KB (656 words) - 16:11, 7 August 2024
"Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering". BioDrugs. 31 (3): 151–166. doi:10.1007/s40259-017-0223-8. PMID 28466278. S2CID 3722081...9 KB (1,041 words) - 06:14, 25 September 2024
Inside of Cells with Biologicals: Toxin Routes in a Therapeutic Context". BioDrugs. 37 (2): 181–203. doi:10.1007/s40259-023-00580-y. PMC 9893211. PMID 36729328...26 KB (2,848 words) - 20:46, 7 October 2024
"Ribonucleases as novel chemotherapeutics : the ranpirnase example". BioDrugs. 22 (1): 53–58. doi:10.2165/00063030-200822010-00006. PMC 2802594. PMID 18215091...8 KB (780 words) - 12:42, 21 October 2023
(April 2019). "Vestronidase alfa: A review in mucopolysaccharidosis VII". BioDrugs. 33 (2): 233–240. doi:10.1007/s40259-019-00344-7. PMC 6469592. PMID 30848434...6 KB (604 words) - 14:55, 22 October 2024
Antibody-Based Cancer Therapeutics Through Glycan Engineering" (PDF). BioDrugs. 31 (3): 151–166. doi:10.1007/s40259-017-0223-8. PMID 28466278. S2CID 3722081...7 KB (509 words) - 18:22, 27 August 2024
Antibody-Based Cancer Therapeutics Through Glycan Engineering" (PDF). BioDrugs. 31 (3): 151–166. doi:10.1007/s40259-017-0223-8. PMID 28466278. S2CID 3722081...6 KB (535 words) - 21:00, 12 May 2024- Antibody-Based Cancer Therapeutics Through Glycan Engineering" (PDF). BioDrugs. 31 (3): 151–166. doi:10.1007/s40259-017-0223-8. PMID 28466278. S2CID 3722081...6 KB (644 words) - 11:47, 13 December 2023
rheumatoid arthritis: folate supplementation should always be given". BioDrugs. 8 (1): 164–75. doi:10.2165/00063030-199708030-00002. PMID 18020507. S2CID 26003509...10 KB (758 words) - 15:46, 22 September 2024- (PDF). U.S. Food and Drug Administration. Keating GM (2008). "Mecasermin". BioDrugs. 22 (3): 177–188. doi:10.2165/00063030-200822030-00004. PMID 18481900....5 KB (314 words) - 09:59, 19 August 2024
type 4 inhibitors: potential in the treatment of multiple sclerosis?". BioDrugs. 13 (2): 87–94. doi:10.2165/00063030-200013020-00002. PMID 18034515. S2CID 23444101...18 KB (1,888 words) - 18:19, 23 October 2024- Related Agents for Chronic Musculoskeletal Pain: A Comprehensive Review". BioDrugs. 35 (6): 611–641. doi:10.1007/s40259-021-00504-8. PMID 34807432. S2CID 244509341...8 KB (645 words) - 02:39, 16 July 2024
- Antibody-Based Cancer Therapeutics Through Glycan Engineering" (PDF). BioDrugs. 31 (3): 151–166. doi:10.1007/s40259-017-0223-8. PMID 28466278. S2CID 3722081...14 KB (957 words) - 14:32, 14 June 2024
Kontermann, RE (2010). "Bispecific antibodies for cancer immunotherapy". BioDrugs. 24 (2): 89–98. doi:10.2165/11530960-000000000-00000. PMID 20199124. S2CID 27797190...12 KB (1,444 words) - 07:52, 29 April 2024- and treatment of children with idiopathic growth hormone deficiency". BioDrugs. 12 (2): 139–157. doi:10.2165/00063030-199912020-00007. PMID 18031173....12 KB (1,281 words) - 15:01, 22 July 2024
- rheumatoid arthritis: folate supplementation should always be given". BioDrugs. 8 (1): 164–75.{{cite journal}}: CS1 maint: multiple names: authors list